Skip to main content Skip to search

YU News

YU News

Walk/Run to Aid Einstein/Montefiore in Promoting Awareness and Prevention of Colorectal Cancer

Mar 2, 2005 -- On Sunday, March 13, 2005, the newly-named Pfizer Oncology Colon Cancer Challenge returned to Central Park, where participants can choose between a 1.7-mile awareness walk, a four-mile co-ed run or men’s half-marathon while running or walking in behalf of colorectal cancer awareness and prevention. The run/walk is the 2nd annual offering presented by the Daily News in support of Partners in Prevention – a program of the Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center that focuses on outreach and research related to colorectal cancer. This year, nearly 5,000 runners and walkers participated in the event and at last count had raised more than 100,000 to benefit Partners in Prevention while learning about prevention and sharing stories of survival. Local news crews from ABC, NBC and CBS broadcast coverage from the event. This year, Pfizer Oncology joined the Daily News and New York Road Runners (NYRR) in teaming with the Albert Einstein College of Medicine and Montefiore Medical Center to bring the run/walk to the tri-state area. And once again, supporters sponsored Challenge participants to help raise funds to aid the research, clinical, and educational efforts of Partners in Prevention. “We set out to make the Colon Cancer Challenge a benchmark in raising public awareness of colorectal cancer and its preventability,” said Thomas K. Weber, M.D., director of Partners In Prevention, as well as associate professor of surgery and molecular genetics at Einstein and chief of surgical oncology at Montefiore. “We were thrilled with the turnout and the generous support we received from sponsors, volunteers, and participants, and we hope to build on that in this year’s Challenge. Having Pfizer Oncology join our team is tremendous and reinforces how important it is to educate everyone we can about the things they can do to reduce their risk of getting colon cancer.” "As we hear these stories of survival, we continue to be inspired by the strength and hope of these patients," said Jeffery Weisberg medical director, Pfizer Oncology. "It is because of this that Pfizer Oncology is dedicated to supporting this educational initiative to raise awareness of colorectal cancer prevention, treatment and continued research." According to the American Cancer Society, cancer is now the leading cause of death, recently surpassing heart disease as the top killer of Americans under age 85. And among non-tobacco-related cancers, colon cancer is the leading cancer killer in the country, second only to lung cancer in cancer-related deaths among Americans. One in ten people have a close relative who has had colon cancer and 1 in 18 will be diagnosed with it. “Cancer has proven to be a formidable opponent that we must keep fighting, and The Daily News is proud to promote this worthy endeavor in support of that fight,” said Les Goodstein, president and COO of the Daily News. “Colon cancer is a serious but treatable disease, and if we can raise awareness and educate people about prevention, perhaps some lives will be saved. People like Dr. Weber and the survivors who share their stories help to make the disease more real and make an embarrassing topic more approachable.” All three “legs” of the Challenge took place in Central Park and finished near Tavern on the Green. For more information on the Challenge visit www.coloncancerchallenge.